Precigen Inc. PGEN
Super Investor & Insider
1
Fondi che lo detengono
#835
Rank consenso
1.4%
% dei portafogli
$69.0M
Valore detenuto
| Fondo | % portaf. | Attività | Azioni | Valore |
|---|---|---|---|---|
| Samantha McLemore · Patient Capital Management | 2.57% | Reduce 4.58% | 17,817,387 | $69.0M |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Precigen Inc. is a discovery and clinical-stage biopharmaceutical company focused on developing gene and cell therapies using precision technology to address diseases in immuno-oncology, autoimmune disorders, and infectious diseases. The company operates through two primary business segments: Biopharmaceuticals and Exe…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees143
TickerPGEN
Statistics
Market Cap$1.68B
Revenue (TTM)$9.7M
Net Income-$250.6M
Net Margin-2588.2%
EPS$-1.37
P/E-3.24
P/S51.12
P/B79.47
EV/EBITDA-16.55
ROE-1145.4%
Dividend Yield—
Price$4.72
Data: Twelve Data · Revenue = mcap / P/S